Alphamab Oncology
Suzhou · Founded 2009
About Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $160.0M
- Funding stage: IPO
- Last round: Series B (May 2019)
- Ticker: hkg:9966
- Website: alphamabonc.com
- Phone: +86-512 6285 0800
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Manufacturing, Oncology
Social Profiles
Canonical: https://fsome.com/organization/alphamab-oncology-49213 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.